Seroepidemiology of Infection with Toxoplasma gondii in General Population in a Central Mexican City
-
José Manuel SALAS-PACHECO
,
Angel Antonio VÉRTIZ-HERNÁNDEZ
,
Ada Agustina SANDOVAL-CARRILLO
,
Azahel de Jesús RANGEL-LÓPEZ
,
Elizabeth Irasema ANTUNA-SALCIDO
,
Sergio Manuel SALAS-PACHECO
,
Luis Francisco SÁNCHEZ-ANGUIANO
,
Edna Madai MÉNDEZ-HERNÁNDEZ
,
Jesús HERNÁNDEZ-TINOCO
,
Francisco Xavier CASTELLANOS-JUÁREZ
,
Osmel LA LLAVE-LEÓN
,
Cosme ALVARADO-ESQUIVEL
Abstract
Abstracts Abstracts Abstracts Abstracts
1. Alvarado-Esquivel C, Estrada-Martínez S, Pizarro-Villalobos H, Arce-Quiñones M, Liesenfeld O, Dubey JP. Seroepidemiology of Toxoplasma gondii in-fection in general population in a northern Mexican city. J Parasitol. 2011;97(1):40-3.
2. Gargaté MJ, Ferreira I, Vilares A, Martins S, Cardo-so C, Silva S, Nunes B, Gomes JP. Toxoplasma gondii seroprevalence in the Portuguese population: com-parison of three cross-sectional studies spanning three decades. BMJ Open. 2016;6(10):e011648.
3. Mosti M, Pinto B, Giromella A, Fabiani S, Cristo-fani R, Panichi M, Bruschi F. A 4-year evaluation of toxoplasmosis seroprevalence in the general popu-lation and in women of reproductive age in central Italy. Epidemiol Infect. 2013;141(10):2192-5.
4. Hofhuis A, van Pelt W, van Duynhoven YT, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Nether-lands between 1995/1996 and 2006/2007. Epi-demiol Infect. 2011;139(4):530-8.
5. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmad-pour E, Shokri A, Rahimi MT, Sharif M. Sero-prevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:185-94.
6. Alvarado-Esquivel C, Rico-Almochantaf YDR, Hernández-Tinoco J, et al. Toxoplasma gondii expo-sure and epilepsy: A matched case-control study in a public hospital in northern Mexico. SAGE Open Med. 2018;6:2050312118767767.
2. Gargaté MJ, Ferreira I, Vilares A, Martins S, Cardo-so C, Silva S, Nunes B, Gomes JP. Toxoplasma gondii seroprevalence in the Portuguese population: com-parison of three cross-sectional studies spanning three decades. BMJ Open. 2016;6(10):e011648.
3. Mosti M, Pinto B, Giromella A, Fabiani S, Cristo-fani R, Panichi M, Bruschi F. A 4-year evaluation of toxoplasmosis seroprevalence in the general popu-lation and in women of reproductive age in central Italy. Epidemiol Infect. 2013;141(10):2192-5.
4. Hofhuis A, van Pelt W, van Duynhoven YT, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Nether-lands between 1995/1996 and 2006/2007. Epi-demiol Infect. 2011;139(4):530-8.
5. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmad-pour E, Shokri A, Rahimi MT, Sharif M. Sero-prevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:185-94.
6. Alvarado-Esquivel C, Rico-Almochantaf YDR, Hernández-Tinoco J, et al. Toxoplasma gondii expo-sure and epilepsy: A matched case-control study in a public hospital in northern Mexico. SAGE Open Med. 2018;6:2050312118767767.
| Files | ||
| Issue | Vol 15 No 1 (2020) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijpa.v15i1.2540 | |
| Keywords | ||
| Keywords Keywords Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
SALAS-PACHECO JM, VÉRTIZ-HERNÁNDEZ AA, SANDOVAL-CARRILLO AA, RANGEL-LÓPEZ A de J, ANTUNA-SALCIDO EI, SALAS-PACHECO SM, SÁNCHEZ-ANGUIANO LF, MÉNDEZ-HERNÁNDEZ EM, HERNÁNDEZ-TINOCO J, CASTELLANOS-JUÁREZ FX, LA LLAVE-LEÓN O, ALVARADO-ESQUIVEL C. Seroepidemiology of Infection with Toxoplasma gondii in General Population in a Central Mexican City. Iran J Parasitol. 2020;15(1):153-154.
